An Open Label, Bioequivalence Study of Sumatriptan Succinate 100 mg Tablets (Containing 140 mg of Sumatriptan Succinate Equivalent to 100 mg Sumatriptan) Under Fasting Conditions
Completed Not Applicable NCT00872924
Study Description
An open label, bioequivalence study of sumatriptan succinate 100 mg tablets (containing 140 mg of sumatriptan succinate equivalent to 100 mg sumatriptan) under fasting Conditions
Study Details
- Registry ID:
- NCT00872924
- Conditions:
- Healthy
- Phase:
- Not Applicable
- Target Enrollment:
- 32 participants
- Start Date:
- Age Range:
- 18–45 years
- Gender:
- Male
- Healthy Volunteers:
- No
Study Locations (1 site)
-
Ranbaxy CPU
Noida, Uttar Pradesh, India
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.